Atea Pharmaceuticals, Inc.
Company Stats
- Market Cap
- $417.9M
- as of Sep 30, 2026
- Shares Outstanding
- 80.2M
- Free Float
- 79.5%
Income Statement
- Operating Income
- -$180.9M
- Net Income
- -$158.3M
- EBITDA
- -$180.5M
Balance Sheet
- Cash & Equivalents
- $95.7M
Returns & Capital
- Share Repurchases
- $25.5M
- SBC, 3Y Avg
- $40.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2022 | — | -$122.9M | — |
| FY2021 | $351.4M | -$87.0M | -24.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 31, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges